Holen Sie sich die Stockscreener-App
1.7489
6.40%
0.1089
Schlusskurs vom Vortag:
$1.64
Offen:
$1.7
24-Stunden-Volumen:
407.11K
Relative Volume:
0.44
Marktkapitalisierung:
$93.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.16M
KGV:
-0.5889
EPS:
-2.97
Netto-Cashflow:
$-130.08M
1W Leistung:
-17.30%
1M Leistung:
+64.62%
6M Leistung:
+256.12%
1J Leistung:
+13.31%
1-Tages-Spanne:
$1.5501
$1.77
1-Wochen-Bereich:
$1.5501
$2.14
52-Wochen-Spanne:
$0.404
$2.27
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Firmenname
Alx Oncology Holdings Inc
Sektor
Branche
Telefon
650-466-7125
Adresse
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALXO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
1.75 | 87.82M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-06 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-19 | Herabstufung | Jefferies | Buy → Hold |
| 2024-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-30 | Eingeleitet | Stifel | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-06 | Eingeleitet | UBS | Buy |
| 2021-02-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-08-11 | Eingeleitet | Credit Suisse | Outperform |
| 2020-08-11 | Eingeleitet | Jefferies | Buy |
| 2020-08-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten
Key metrics from ALX Oncology Holdings Inc.’s quarterly dataWeekly Gains Summary & Smart Investment Allocation Tips - newser.com
Real time breakdown of ALX Oncology Holdings Inc. stock performanceCEO Change & High Return Trade Opportunity Guides - newser.com
Relative strength of ALX Oncology Holdings Inc. in sector analysisJuly 2025 Spike Watch & Capital Protection Trading Alerts - newser.com
Is ALX Oncology Holdings Inc a good long term investmentMoving Average Crossovers & Free High Yield Market Plays - earlytimes.in
Chart based analysis of ALX Oncology Holdings Inc. trendsMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
ALX Oncology (NASDAQ:ALXO) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
How moving averages guide ALX Oncology Holdings Inc. trading2025 EndofYear Setup & Low Risk High Reward Ideas - newser.com
Is ALX Oncology Holdings Inc. still worth holding after the dipJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 - GlobeNewswire
ALX Oncology to present CD47 biomarker data for evorpacept at SITC - Investing.com Nigeria
ALX Oncology to present CD47 biomarker data for evorpacept at SITC By Investing.com - Investing.com South Africa
Upcoming Events - FinancialContent
ALX Oncology Holdings Inc Stock Analysis and ForecastGrowth vs. Value Investing & Exceptional Return Investment - earlytimes.in
Revolution Medicines hires Mirati, ALX vet Sandler - biocentury.com
ALX Oncology Holdings (ALXO) Price Target Increased by 18.52% to 2.72 - Nasdaq
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer - GlobeNewswire Inc.
Goldman Sachs Group Inc. Sells 195,795 Shares of ALX Oncology Holdings Inc. $ALXO - Defense World
Pan India Corporation Limited Earnings Review What Investors Need to KnowGrowth vs. Value Investing & Interactive Charts for Smarter Trading - earlytimes.in
What analysts say about ALX Oncology Holdings Inc stockMean Reversion Trades & Big Gains Small Investment - earlytimes.in
ALX Oncology Holdings Inc. stock retracement – recovery analysisEarnings Growth Report & High Return Stock Watch Alerts - newser.com
What to do if you’re stuck in ALX Oncology Holdings Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com
3 Promising Penny Stocks With Market Caps Under $700M - Yahoo Finance
What earnings revisions data tells us about ALX Oncology Holdings Inc.2025 Investor Takeaways & Daily Price Action Insights - newser.com
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
ALX Oncology (NASDAQ:ALXO) CEO Jason Lettmann Buys 21,070 Shares - MarketBeat
Is now a turning point for ALX Oncology Holdings Inc.July 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
ALX Oncology (NASDAQ:ALXO) CEO Jason Lettmann Buys 71,163 Shares - MarketBeat
CEO & Director of ALX Oncology Holdings Picks Up 69% More Stock - Yahoo Finance
Trend Recap: Is SYTA backed by strong institutional buyingJuly 2025 Rallies & Free Accurate Trade Setup Notifications - خودرو بانک
Portfolio Update: How volatile is ALX Oncology Holdings Inc stockJuly 2025 Drop Watch & AI Based Trade Execution Alerts - khodrobank.com
Will ALX Oncology Holdings Inc. rebound enough to break evenMarket Movers & Fast Exit Strategy with Risk Control - newser.com
Volatility Watch: Will ALX Oncology Holdings Inc. outperform tech stocksRate Hike & Stepwise Trade Execution Plans - khodrobank.com
Day Trade: Can ALX Oncology Holdings Inc beat the S P 5002025 Year in Review & Fast Gaining Stock Reports - khodrobank.com
Can technical indicators confirm ALX Oncology Holdings Inc.’s reversalQuarterly Trade Review & Entry and Exit Point Strategies - newser.com
Chipmakers Recap: Will ALX Oncology Holdings Inc stock hit new highs in YEARJuly 2025 Action & Accurate Intraday Trade Tips - خودرو بانک
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alx Oncology Holdings Inc-Aktie (ALXO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Sep 16 '25 |
Buy |
1.07 |
21,070 |
22,461 |
233,958 |
| Shantharam Harish | Chief Financial Officer |
Aug 18 '25 |
Buy |
0.78 |
75,000 |
58,402 |
75,000 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Aug 15 '25 |
Sale |
0.64 |
611 |
391 |
89,198 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Aug 15 '25 |
Sale |
0.64 |
2,382 |
1,525 |
212,888 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Jul 07 '25 |
Sale |
0.45 |
2,011 |
905 |
86,809 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Jun 30 '25 |
Sale |
0.43 |
1,532 |
659 |
88,820 |
| Pinto Shelly | SVP, FINANCE AND CAO |
Feb 19 '25 |
Sale |
1.15 |
550 |
633 |
87,352 |
| Pons Jaume | PRESIDENT & CSO |
Feb 19 '25 |
Sale |
1.15 |
1,326 |
1,525 |
579,388 |
| Lettmann Jason | CHIEF EXECUTIVE OFFICER |
Feb 19 '25 |
Sale |
1.15 |
2,159 |
2,483 |
170,270 |
| Pinto Shelly | Interim CFO |
Jan 06 '25 |
Sale |
1.80 |
2,221 |
3,998 |
87,902 |
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):